Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 NOK | -0.95% | -5.45% | -20.61% |
Mar. 14 | Hofseth BioCare ASA Announces Board Changes | CI |
Feb. 09 | Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Sales 2021 | 87.62M 8.08M | Sales 2022 | 120M 11.11M | Capitalization | 1.3B 120M |
---|---|---|---|---|---|
Net income 2021 | -126M -11.62M | Net income 2022 | -137M -12.63M | EV / Sales 2021 | 29.2 x |
Net Debt 2021 | 89.26M 8.23M | Net Debt 2022 | 71.74M 6.61M | EV / Sales 2022 | 11.4 x |
P/E ratio 2021 |
-19.5
x | P/E ratio 2022 |
-8.89
x | Employees | 60 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 41.73% |
1 day | -0.95% | ||
1 week | -5.45% | ||
Current month | -11.49% | ||
1 month | -12.24% | ||
3 months | -20.31% | ||
6 months | -24.09% | ||
Current year | -20.61% |
Managers | Title | Age | Since |
---|---|---|---|
Jon Olav Ødegård
CEO | Chief Executive Officer | 51 | 13-02-28 |
Roger Hofseth
FOU | Founder | 50 | 99-12-31 |
Crawford Currie
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Roger Hofseth
FOU | Founder | 50 | 99-12-31 |
Director/Board Member | 53 | 15-04-30 | |
Director/Board Member | 49 | 15-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 2.08 | -0.95% | 101,573 |
24-03-26 | 2.1 | -5.83% | 159,915 |
24-03-25 | 2.23 | 0.00% | 23,471 |
24-03-22 | 2.23 | +2.76% | 54,567 |
24-03-21 | 2.17 | -1.36% | 111,664 |
Real-time Oslo Bors, March 27, 2024 at 09:20 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-20.61% | 76.13M | |
-1.80% | 278B | |
-3.38% | 94.39B | |
-0.26% | 44.41B | |
+2.06% | 41.48B | |
+4.66% | 39.56B | |
+7.83% | 39.33B | |
-12.57% | 32.12B | |
-1.36% | 29.71B | |
+5.53% | 23.78B |